| Twist Bioscience Corporation | 1,548 | US$159K | 5.9% |
| Moderna, Inc. | 1,584 | US$111K | 4.1% |
| Eli Lilly And Company | 91 | US$109K | 4.1% |
| Johnson & Johnson | 313 | US$79,493 | 3.0% |
| United Therapeutics Corporation | 121 | US$65,561 | 2.4% |
| Natera, Inc. | 229 | US$62,162 | 2.3% |
| Tempus Ai, Inc. | 1,055 | US$61,116 | 2.3% |
| Immunome, Inc. | 2,850 | US$60,392 | 2.3% |
| Stoke Therapeutics, Inc. | 1,712 | US$56,017 | 2.1% |
| Beam Therapeutics Inc. | 1,628 | US$55,873 | 2.1% |
| Corteva, Inc. | 629 | US$53,270 | 2.0% |
| Krystal Biotech, Inc. | 141 | US$52,405 | 2.0% |
| Darling Ingredients Inc. | 949 | US$51,834 | 1.9% |
| Ionis Pharmaceuticals, Inc. | 627 | US$49,715 | 1.9% |
| Astrazeneca Plc | 258 | US$48,922 | 1.8% |
| 10x Genomics, Inc. | 1,264 | US$48,462 | 1.8% |
| Crispr Therapeutics Ag | 868 | US$47,341 | 1.8% |
| Roivant Sciences Ltd. | 1,310 | US$46,361 | 1.7% |
| Absci Corporation | 3,939 | US$45,653 | 1.7% |
| Revolution Medicines, Inc. | 241 | US$45,134 | 1.7% |
| Agios Pharmaceuticals, Inc. | 1,134 | US$42,083 | 1.6% |
| Amgen Inc. | 114 | US$41,282 | 1.5% |
| Bayer Ag | 741 | US$41,012 | 1.5% |
| Thermo Fisher Scientific Inc | 81 | US$40,610 | 1.5% |
| Gilead Sciences, Inc. | 320 | US$40,429 | 1.5% |
| Bunge Limited | 378 | US$40,344 | 1.5% |
| Arrowhead Pharmaceuticals, Inc. | 484 | US$39,451 | 1.5% |
| Veracyte, Inc. | 666 | US$39,114 | 1.5% |
| Biohaven Ltd. | 2,473 | US$36,798 | 1.4% |
| Novonesis A/s Class B | 582 | US$36,756 | 1.4% |
| Pfizer, Inc. | 1,494 | US$35,976 | 1.3% |
| Vertex Pharmaceuticals Incorporated | 72 | US$35,765 | 1.3% |
| Novartis Ag | 227 | US$35,621 | 1.3% |
| Uniqure N.v. | 713 | US$32,841 | 1.2% |
| Catalyst Pharmaceuticals, Inc. | 914 | US$28,727 | 1.1% |
| Exelixis, Inc. | 514 | US$27,967 | 1.0% |
| Cullinan Therapeutics, Inc. | 1,532 | US$27,898 | 1.0% |
| Protagonist Therapeutics, Inc. | 224 | US$27,458 | 1.0% |
| Dyne Therapeutics, Inc. | 1,205 | US$26,763 | 1.00% |
| Celldex Therapeutics, Inc. | 694 | US$25,824 | 0.96% |
| Editas Medicine, Inc. | 7,881 | US$25,534 | 0.95% |
| Argenx Se | 27 | US$25,050 | 0.94% |
| Viking Therapeutics, Inc. | 639 | US$24,927 | 0.93% |
| Regenxbio Inc. | 2,079 | US$24,906 | 0.93% |
| Cg Oncology, Inc. | 340 | US$24,157 | 0.90% |
| Biogen Inc. | 102 | US$22,038 | 0.82% |
| Allogene Therapeutics, Inc. | 10,528 | US$21,898 | 0.82% |
| Iovance Biotherapeutics, Inc. | 4,942 | US$20,559 | 0.77% |
| Danaher Corporation | 105 | US$20,000 | 0.75% |
| Repligen Corporation | 142 | US$19,374 | 0.72% |
| Merck & Company, Inc. | 146 | US$18,761 | 0.70% |
| Sana Biotechnology, Inc. | 5,156 | US$17,994 | 0.67% |
| Verbio Se | 520 | US$17,717 | 0.66% |
| Halozyme Therapeutics, Inc. | 222 | US$17,376 | 0.65% |
| Ultragenyx Pharmaceutical Inc. | 479 | US$15,994 | 0.60% |
| Syensqo Sa/nv | 214 | US$15,805 | 0.59% |
| Fmc Corporation | 1,357 | US$15,606 | 0.58% |
| Insmed Incorporated | 146 | US$15,567 | 0.58% |
| Green Plains, Inc. | 1,010 | US$15,534 | 0.58% |
| Arcturus Therapeutics Holdings Inc. | 2,185 | US$14,683 | 0.55% |
| Illumina, Inc. | 82 | US$14,418 | 0.54% |
| Regeneron Pharmaceuticals, Inc. | 23 | US$14,341 | 0.54% |
| Intellia Therapeutics, Inc. | 841 | US$14,230 | 0.53% |
| Nufarm Limited | 7,097 | US$13,325 | 0.50% |
| Bio-techne Corp | 185 | US$13,070 | 0.49% |
| Bridgebio Pharma, Inc. | 172 | US$12,811 | 0.48% |
| Biomarin Pharmaceutical Inc. | 204 | US$11,673 | 0.44% |
| Genmab A/s | 41 | US$11,208 | 0.42% |
| Oxford Nanopore Technologies Plc | 6,496 | US$10,700 | 0.40% |
| Zoetis Inc. | 135 | US$9,701 | 0.36% |
| Genus Plc | 320 | US$9,123 | 0.34% |
| Geron Corporation | 6,841 | US$8,756 | 0.33% |
| Tyson Foods, Inc. | 138 | US$7,901 | 0.30% |
| Rocket Pharmaceuticals, Inc. | 2,310 | US$7,900 | 0.30% |
| Alnylam Pharmaceuticals, Inc. | 26 | US$7,827 | 0.29% |
| Sarepta Therapeutics, Inc. | 419 | US$7,529 | 0.28% |
| Pacific Biosciences Of California, Inc. | 4,222 | US$7,093 | 0.26% |
| Qiagen N.v. | 172 | US$6,725 | 0.25% |
| Ginkgo Bioworks Holdings, Inc. | 0 | US$0 | 0.00% |
| Takeda Pharmaceutical Co. Ltd. | 0 | US$0 | 0.00% |
| Fate Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Schrodinger, Inc. | 0 | US$0 | 0.00% |
| Novo Nordisk A/s Class B | 0 | US$0 | 0.00% |
| Bristol-myers Squibb Company | 0 | US$0 | 0.00% |
| Zealand Pharma A/s | 0 | US$0 | 0.00% |
| Recursion Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Caribou Biosciences, Inc. | 0 | US$0 | 0.00% |